Alliance for Pandemic Preparedness

December 4, 2020

COVID-19 Investigational Treatments in Use among Hospitalized Patients Identified through the U.S. Coronavirus Disease 2019 -Associated Hospitalization Surveillance Network, March 1–June 30, 2020

Category:

Topic:

Keywords (Tags):

  • Data analyzed from the COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) indicate that among hospitalized individuals in the US with COVID-19 and with available data from March 1–June 30, 43% of received at least one COVID-19 investigational treatment. Hydroxychloroquine, azithromycin, and remdesivir were used frequently; however, hydroxychloroquine and azithromycin use declined over time, while use of remdesivir increased.

Acosta et al. (Nov 9, 2020). COVID-19 Investigational Treatments in Use among Hospitalized Patients Identified through the U.S. Coronavirus Disease 2019 -Associated Hospitalization Surveillance Network, March 1–June 30, 2020. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofaa528